Close
Smartlab Europe
Inizio Ignite

News

Why Use a Provider Network for Pain Management After an Accident?

Pain after an accident can be overwhelming and can affect every part of life. Injuries can make moving, resting, and handling everyday tasks hard. Getting treatment quickly is important to avoid long-term discomfort and additional complications. A provider network...

How Early Regulatory Planning Saves Time and Money in Product Development

Incorporating early regulatory planning in product development can significantly reduce costs and enhance efficiency. Collaborating with regulatory experts ensures thorough evaluations and strategic planning, optimizing resources and streamlining manufacturing processes. The medical device industry faces numerous regulatory challenges that can...

America’s AI Action Plan Boosts Pharmaceutical Innovation

Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel the United States to the forefront of global AI leadership. Within its three pillars—innovation, infrastructure,...

Trump To Roll-Out 340B Drugs Discount Program in 2026

The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that are participating in the 340B drugs discount program. The pilot happens to depart from the...

60-Day Window by Trump for Firms to Lower Their Drug Prices

President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been posted by Trump on social media Say name-brand drug prices are almost three times...

Canada-UK Partnership Integrates Bioreactor Technologies

In a recent move, an international initiative is going to transform biologics as well as drug manufacturing by way of AI-driven multi-platform integration. The AI-optimized BALANCE (Bioreactor automation for learning and adaptive networked control of experiments) platform is going...

Bavarian Nordic Agrees for a $3 Bn Take-Private Offer

Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms Permira and Nordic Capital. Apparently, the board of directors of the company plan to unanimously...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »